Momenta Pharmaceuticals, Inc. (MNTA)

[biopearl]

The amicus curare filed by the DOJ is yet another voice suggesting an eventual ruling in favor of MNTA/Sandoz upon remand thus making an at risk launch even less risky but still uncertain. The holdup is not a fear of successful TEVA litigation at this point IMO, but simply still is a direct reflection of the FDAs plodding analysis of something, who knows what? TEVA has done everything they can to delay including their genetic data which as Dew has pointed out may be the last hurdle. In any case given the likelyhood of ultimate success in the courts, now confirmed by the DOJ filing, I think Sandoz/MNTA will launch as soon as FDA approval occurs. Each day of delay is worth 9 million to TEVA. bp